Factor V leiden mutation and high FVIII are associated with an increased risk of VTE in women with breast cancer during adjuvant tamoxifen - results from a prospective, single center, case control study

Kovac, Mirjana K; Kovac, Zeljko; Tomasevic, Zorica I; Vucicevic, Slavko S; Djordjevic, Valentina J; Pruner, Iva B; Radojkovic, Dragica P

Rezultati

eNauka > Rezultati > Factor V leiden mutation and high FVIII are associated with an increased risk of VTE in women with breast cancer during adjuvant tamoxifen - results from a prospective, single center, case control study

Naziv :	Factor V leiden mutation and high FVIII are associated with an increased risk of VTE in women with breast cancer during adjuvant tamoxifen - results from a prospective, single center, case control study
Autori:	Kovac, Mirjana K ; Kovac, Zeljko; Tomasevic, Zorica I ; Vucicevic, Slavko S; Djordjevic, Valentina J ; Pruner, Iva B ; Radojkovic, Dragica P
Godina:	2015
Publikacija:	JOURNAL OF THROMBOSIS AND HAEMOSTASIS
ISSN:	1538-7933 Journal of Thrombosis and Haemostasis Pretraži identifikator
Tip rezultata:	Konferencijski rad
Kolacija:	vol. 13 br. Supplement 2 str. 810-810
WoS-ID:	000356426904554
URI:	https://enauka.gov.rs/handle/123456789/806446
URL:	https://www.webofscience.com/wos/woscc/full-record/WOS:000356426904554
Izvor metapodataka:	(Preuzeto iz Nasi u WoS)
Napomena o dostupnosti:	Пуни текст није јавно доступан
M-kategorija:	Mp kategorija će biti prikazana naknadno.

Pronađi DOI

Pronalaženje DOI u servisu CrossRef-u na osnovu meta-podataka u zapisu. Prikazaće se DOI (i metapodaci) čiji se podaci najviše poklapaju. OPREZ - to ne mora biti ta publikacija.

Google Scholar^TM

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.